Patients with advanced Merkel cell carcinoma had significant increases in survival rates following FDA approval of immune checkpoint inhibitors.
The detection of metastases in Merkel cell carcinoma (MCC) requires additional testing, such as pancytokeratin (panCK) or CK20, with no guarantee of success. Recent findings have identified ...
Negative surgical margins regardless of surgery type was associated with increased overall survival in patients with Merkel cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback